CSV export
Details about the neuroanatomical projections from SUBv to NLOT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88578 | Subiculum ventral part | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Only a few BDA-labeled fibers were scattered in the anterior amygdaloid area and nucleus of the lateral olfactory tract at a rostralmost level. Collator note: projection not shown | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88681 | Subiculum ventral part | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88744 | Subiculum ventral part | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88778 | Subiculum ventral part | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88807 | Subiculum ventral part | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to MEAad
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88579 | Subiculum ventral part | Medial nucleus of the amygdala anterodorsal part | moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the MEAad, caudally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88592 | Subiculum ventral part | Medial nucleus of the amygdala anterodorsal part | moderate | biotinylated dextran amine (BDA) | Proceeding caudally, more labeled fibers were distributed in the Me (Fig. 3B). Collator note: at least moderate labeling of the rostral MEAad. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88665 | Subiculum ventral part | Medial nucleus of the amygdala anterodorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: terminals in the MEAad, continuing dorsally in CEA. See Fig. 5A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88756 | Subiculum ventral part | Medial nucleus of the amygdala anterodorsal part | moderate | biotinylated dextran amine (BDA) | Collator note: moderate labeling of the caudal MEAad. See Fig. 10A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88789 | Subiculum ventral part | Medial nucleus of the amygdala anterodorsal part | light | biotinylated dextran amine (BDA) | Collator note: few labeled fibers in the caudal MEAad See Fig. 12A, Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to MEAav
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88580 | Subiculum ventral part | Medial nucleus of the amygdala anteroventral part | very light | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: few labeled fibers in this regions, if any, caudally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88664 | Subiculum ventral part | Medial nucleus of the amygdala anteroventral part | not present | biotinylated dextran amine (BDA) | Collator note: the MEAav seems void of label, at least caudally. See Fig. 5A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88718 | Subiculum ventral part | Medial nucleus of the amygdala anteroventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88757 | Subiculum ventral part | Medial nucleus of the amygdala anteroventral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal MEAav and the neighboring BA. See Fig. 10A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88793 | Subiculum ventral part | Medial nucleus of the amygdala anteroventral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to CEAm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88582 | Subiculum ventral part | Central nucleus of amygdala medial part | light/moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: weak-moderate labeling of CEAm, caudally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88596 | Subiculum ventral part | Central nucleus of amygdala medial part | light/moderate | biotinylated dextran amine (BDA) | The central nucleus displayed light labeling, which was almost localized in the CeM (Fig. 3B). Collator note: see Fig. 3B, Swanson Atlas Levels 27-28, | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88605 | Subiculum ventral part | Central nucleus of amygdala medial part | light/moderate | biotinylated dextran amine (BDA) | At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88608 | Subiculum ventral part | Central nucleus of amygdala medial part | light/moderate | biotinylated dextran amine (BDA) | A few labeled fibers ran along the medial edge of the central nucleus (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88667 | Subiculum ventral part | Central nucleus of amygdala medial part | moderate/strong | biotinylated dextran amine (BDA) | Collator note: see Fig. 5C, Swanson Atlas Levels 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88731 | Subiculum ventral part | Central nucleus of amygdala medial part | light | biotinylated dextran amine (BDA) | Collator note: few labeled fibers in the medial part of the CEAm. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88769 | Subiculum ventral part | Central nucleus of amygdala medial part | light | biotinylated dextran amine (BDA) | Collator note: few terminals and fibers in the CEAl and m. See Fig. 10A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88788 | Subiculum ventral part | Central nucleus of amygdala medial part | light | biotinylated dextran amine (BDA) | Collator note: few labeled fibers in the rostral CEAm, and in the ventral CEAc. See Fig. 12A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to CEAl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88583 | Subiculum ventral part | Central nucleus of amygdala lateral part | very light | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: very sparse labeling of CEAl, caudally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88597 | Subiculum ventral part | Central nucleus of amygdala lateral part | very light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in the CEAl, dorsally. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88607 | Subiculum ventral part | Central nucleus of amygdala lateral part | light/moderate | biotinylated dextran amine (BDA) | A few labeled fibers ran along the medial edge of the central nucleus (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88668 | Subiculum ventral part | Central nucleus of amygdala lateral part | very light | biotinylated dextran amine (BDA) | Collator note: see Fig. 5A-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88732 | Subiculum ventral part | Central nucleus of amygdala lateral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. See Fig. 8A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88770 | Subiculum ventral part | Central nucleus of amygdala lateral part | light | biotinylated dextran amine (BDA) | Collator note: few terminals and fibers in the CEAl and m. See Fig. 10A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88792 | Subiculum ventral part | Central nucleus of amygdala lateral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to CEAc
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88584 | Subiculum ventral part | Central nucleus of amygdala capsular part | light/moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: labeled terminals in the ventral sector of the CEAc, close to IA. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88593 | Subiculum ventral part | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | An area lateral to the Me, the intra-amygdaloid division of the bed nucleus of the stria terminalis (BSTIA), contained a moderate number of labeled fibers (Fig. 3B). Collator note: BSTIA is mapped here onto CEAc, ventral part and the lateral part of the MEApd. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88598 | Subiculum ventral part | Central nucleus of amygdala capsular part | light | biotinylated dextran amine (BDA) | Collator note: sparse labeling of the dorsal CEAc in this level, dorsally and ventrally. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88604 | Subiculum ventral part | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88666 | Subiculum ventral part | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | Collator note: the capsular CEA, especially rostroventrally is labeled moderately. See Fig. 5A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88730 | Subiculum ventral part | Central nucleus of amygdala capsular part | light/moderate | biotinylated dextran amine (BDA) | Collator note: the label in CEAc is concentrated ventrally. See Fig. 8A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88755 | Subiculum ventral part | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | Collator note: moderate labeling in the caudal part of the ventral CEAc. See Fig. 10B-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88787 | Subiculum ventral part | Central nucleus of amygdala capsular part | light | biotinylated dextran amine (BDA) | Collator note: few labeled fibers in the rostral CEAm, and in the ventral CEAc. See Fig. 12A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to IA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88585 | Subiculum ventral part | Intercalated nuclei of the amygdala | moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: labeled terminals in the IA. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88594 | Subiculum ventral part | Intercalated nuclei of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | Collator note: strong-moderately dense labeling of the IA in this level. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88603 | Subiculum ventral part | Intercalated nuclei of the amygdala | moderate | biotinylated dextran amine (BDA) | At this level, the intercalated nucleus and adjacent area of the BSTIA displayed light-to-moderate labeling (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88662 | Subiculum ventral part | Intercalated nuclei of the amygdala | very light | biotinylated dextran amine (BDA) | […] the intercalated nucleus tended to be devoid of labeling (Fig. 5B). Collator note: Fig. 5A-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88729 | Subiculum ventral part | Intercalated nuclei of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: IA is practically devoid of label. See fig. 8A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88754 | Subiculum ventral part | Intercalated nuclei of the amygdala | moderate | biotinylated dextran amine (BDA) | Collator note: moderate labeling in the caudalmost part of the IA. See Fig. 10B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88801 | Subiculum ventral part | Intercalated nuclei of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to BMAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88586 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the BMAa in this level. The terminals tend to group dorsally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88595 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | strong | biotinylated dextran amine (BDA) | Dense labeling was seen in the BMA, mainly in the dorsomedial portion of this nucleus (Fig. 3B). Collator note: see Fig. 3B, Swanson Atlas Levels 27-28, | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88657 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | moderate/strong | biotinylated dextran amine (BDA) | the full extent of the BMA and BMP displayed moderate-to-intense labeling, although the ventral and lateral edges of both nuclei tended to contain fewer labeled axons (Figs. 5A–D, 6A,B). Collator note: Fig. 5A-B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88714 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | The BMA also displayed weak-to-moderate labeling. Collator note: caudally, BMAa looks moderately labeled. See Fig. 8B, Swanson Atlas Level 28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88715 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | The BMA also displayed weak-to-moderate labeling. Collator note: see Fig. 8A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88786 | Subiculum ventral part | Basomedial nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the BMAa, rostrocaudally. See Fig. 12 A-B, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to LHA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88587 | Subiculum ventral part | Lateral hypothalamic area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the LHA, just above the optic tract. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to EPd
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88588 | Subiculum ventral part | Endopiriform nucleus dorsal part | light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in the Epd, in the medial part. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88620 | Subiculum ventral part | Endopiriform nucleus dorsal part | light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in the caudalmost part of the Epd. See Fig. 3C-D, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88678 | Subiculum ventral part | Endopiriform nucleus dorsal part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the EPd, at least caudally. See Fig. 5A-E, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88738 | Subiculum ventral part | Endopiriform nucleus dorsal part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal part of the EPd. See fig. 8 A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88771 | Subiculum ventral part | Endopiriform nucleus dorsal part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal part of the EPd. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88790 | Subiculum ventral part | Endopiriform nucleus dorsal part | very light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in a single level of the EPd. See Fig. 12C, Swanson Atlas Level 29 | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to SI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88590 | Subiculum ventral part | Substantia innominata | moderate | biotinylated dextran amine (BDA) | Labeled fibers were sparsely distributed in the medial nucleus (Me) and adjacent region of the substantia innominata, medial division of the central nucleus (CeM), intercalated nucleus, and dorsomedial region of the anterior basomedial nucleus (BMA; Fig 3A). Collator note: moderate labeling of the SI in this level. The terminals tend to group dorsally. See Fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to MEApd
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88591 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | strong | biotinylated dextran amine (BDA) | Proceeding caudally, more labeled fibers were distributed in the Me (Fig. 3B). Collator note: strong labeling of the rostral MEApd. See Fig. 3B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88601 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | moderate | biotinylated dextran amine (BDA) | relatively small numbers of labeled fibers tended to terminate in the ventral and lateral parts of the Me (Fig. 3C). Collator note: terminal field in the lateral part of the MEApd, continuing in the MEApv. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88670 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | moderate | biotinylated dextran amine (BDA) | Collator note: See Fig. 5B-C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88716 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | very light | biotinylated dextran amine (BDA) | At caudal levels, medial amygdaloid regions were almost free from labeling (Fig. 8C,D). Collator note: Fig 8C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88720 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88759 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: weak-moderate labeling of the rostral MEAad. See Fig. 10B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88762 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | very light | biotinylated dextran amine (BDA) | Collator note: very few terminals in the lateral part of the caudal MEApd. See Fig. 10C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88794 | Subiculum ventral part | Medial nucleus of the amygdala posterodorsal part | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to COAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88599 | Subiculum ventral part | Cortical nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | Scant labeling was also seen in the medial (PMCo) and lateral (PLCo) divisions of the posterior cortical nucleus (Fig. 3B). Collator note: Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88672 | Subiculum ventral part | Cortical nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the caudal COAa, layer II. See Fig. 5A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88711 | Subiculum ventral part | Cortical nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | Small numbers of Si (caudal SUBv) fibers terminated in the corticomedial nuclear group at rostral levels (Fig. 8A,B). Collator note: fibers and terminals in the COAa, layer II. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88763 | Subiculum ventral part | Cortical nucleus of the amygdala anterior part | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the COAa. See Fig. 10A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88791 | Subiculum ventral part | Cortical nucleus of the amygdala anterior part | very light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals and fibers in the COAa. See Fig. 12A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to COApl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88600 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | light | biotinylated dextran amine (BDA) | Scant labeling was also seen in the medial (PMCo) and lateral (PLCo) divisions of the posterior cortical nucleus (Fig. 3B). Collator note: Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88621 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | very light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in the COApl, mostly caudally. See Fig. 3C-D, Swanson Atlas Levels 28-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88673 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | light | biotinylated dextran amine (BDA) | Collator note: labeling of the rostral COApl, layer II. See Fig. 5B, Swanson Atlas Level 28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88713 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. See Fig. 8A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88764 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | light | biotinylated dextran amine (BDA) | Collator note: few terminals in layer 3 of the COApl. See Fig. 10B-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88766 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | light/moderate | biotinylated dextran amine (BDA) | Collator note: terminals in layer 3 of the caudal COApl. See Fig. 10D, Swanson Atlas Levels 30-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88795 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part lateral zone | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to MEApv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88602 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | moderate | biotinylated dextran amine (BDA) | relatively small numbers of labeled fibers tended to terminate in the ventral and lateral parts of the Me (Fig. 3C). Collator note: terminal field in the lateral part of the MEApd, continuing in the MEApv. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88671 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | moderate | biotinylated dextran amine (BDA) | Collator note: See Fig. 5B-C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88717 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | very light | biotinylated dextran amine (BDA) | At caudal levels, medial amygdaloid regions were almost free from labeling (Fig. 8C,D). Collator note: Fig 8C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88719 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88721 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: the caudal parts of the MEAa and the rostral ones of the MEAp are weak-moderately labeled. See Fig. 8A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88760 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the rostral MEApv. See Fig. 10B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88761 | Subiculum ventral part | Medial nucleus of the amygdala posteroventral part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the MEApv. See Fig. 10C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to BMAp
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88606 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | moderate | biotinylated dextran amine (BDA) | Relatively weak labeling was seen in the dorsomedial part of the posterior basomedical nucleus (BMP) (Fig. 3C). See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88615 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | strong | biotinylated dextran amine (BDA) | A dense plexus of labeled fibers was present in the dorsomedial quadrant of the BMP (Fig. 3D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88658 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | moderate/strong | biotinylated dextran amine (BDA) | the full extent of the BMA and BMP displayed moderate-to-intense labeling, although the ventral and lateral edges of both nuclei tended to contain fewer labeled axons (Figs. 5A–D, 6A,B). Collator note: Fig. 5C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88722 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | moderate/strong | biotinylated dextran amine (BDA) | [..] the BMP contained a relatively large number of labeled fibers, which were concentrated in the lateral half in the rostral part of this nucleus (Fig. 8C) and in the medial half in its caudal part (Fig. 8D). Collator note: Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88750 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | very strong | biotinylated dextran amine (BDA) | An exceedingly large number of labeled fibers formed a terminal network involving the entire extent of the BMP and BLV (Figs. 10C, 11B). Collator note: Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88753 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | light | biotinylated dextran amine (BDA) | Collator note: few labeled fibers and terminals in the caudal part of the BMAp. See Fig. 10D, Swanson Atlas Levels 30-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88785 | Subiculum ventral part | Basomedial nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the BMAp, rostrocaudally. See Fig. 12 B-D, Swanson Atlas Levels 27-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to BLAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88581 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | not present | biotinylated dextran amine (BDA) | Collator note: no labeled fibers in this level. See fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88609 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | Scant labeling was detected in the anterior basolateral nucleus (BLA) and lateral nucleus (La; Fig. 3C). Collator note: label found in the ventral part of the BLAa. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88611 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the rostral parts of the LA and BLAa, respectively. See Fig 3A-B, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88656 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | The distribution density of labeled fibers in the basolateral nuclear group was higher in case R64. Collator note: Fig. 5C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88660 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | light | biotinylated dextran amine (BDA) | Collator note: weak labeling in the rostral part of this nucleus. See fig. 5A-B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88723 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | strong | biotinylated dextran amine (BDA) | A concentration of labeled fibers was seen in the dorsomedial quadrant of the BLA (Fig. 8B,C). Collator note: Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88745 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | […] moderate numbers of labeled fibers were distributed diffusely in the BLA and were concentrated in the middle one-third of the dorsoventral extent of the La (Figs. 10A, 11A). Collator note: Swanson Atlas Levels 26-27 | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88747 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | very strong | biotinylated dextran amine (BDA) | Collator note: very strong labeling in the medial corner of the caudal BLAa. See Fig. 10C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88780 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | moderate/strong | biotinylated dextran amine (BDA) | […] labeled fibers formed a plexus of labeled axons in an area involving the ventromedial La and adjacent portion of the BLA. Collator note: Fig. 12B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88782 | Subiculum ventral part | Basolateral nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in BLAa, tending to agglomerate laterally in this level. See Fig. 12C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to LA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88589 | Subiculum ventral part | Lateral nucleus of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: no labeled fibers in this level. See fig. 3A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88610 | Subiculum ventral part | Lateral nucleus of the amygdala | light | biotinylated dextran amine (BDA) | Scant labeling was detected in the anterior basolateral nucleus (BLA) and lateral nucleus (La; Fig. 3C). Collator note: labeld in the medial part of the LA. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88612 | Subiculum ventral part | Lateral nucleus of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: no label in the rostral parts of the LA and BLAa, respectively. See Fig 3A-B, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88617 | Subiculum ventral part | Lateral nucleus of the amygdala | very light | biotinylated dextran amine (BDA) | Only a few labeled fibers were scattered in the ventromedial part of the La (Fig. 3D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88669 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | Collator note: distinct terminal field in the LA, caudalmost, and restricted to the ventral part. See Fig. 5C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88724 | Subiculum ventral part | Lateral nucleus of the amygdala | light/moderate | biotinylated dextran amine (BDA) | […] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: a diagonal field traverses LA in this level. Swanson Atlas Level 28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88725 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate | biotinylated dextran amine (BDA) | […] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: label concentrated in the ventral half of the nucleus. Fig. 8C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88726 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | […] the ventromedial part of the La showed scant labeling (Fig. 8B,C), whereas moderate labeling was observed in the ventral and lateral regions of the La at more caudal levels (Fig. 8D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88746 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | […] moderate numbers of labeled fibers were distributed diffusely in the BLA and were concentrated in the middle one-third of the dorsoventral extent of the La (Figs. 10A, 11A). Collator note: the terminal field in the ventral LA is present almost in the rostro-caudal extent. See fig. 10A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88752 | Subiculum ventral part | Lateral nucleus of the amygdala | light | biotinylated dextran amine (BDA) | [….] limited numbers of labeled fibers were scattered in the ventrolateral part of the La (Fig. 10D). Collator note: Swanson Atlas Levels 30-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88779 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | […] labeled fibers formed a plexus of labeled axons in an area involving the ventromedial La and adjacent portion of the BLA. Collator note: Fig. 12B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88781 | Subiculum ventral part | Lateral nucleus of the amygdala | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the ventrolateral corner of the mid-rostrocaudal LA. See Fig. 12C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to PA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88613 | Subiculum ventral part | Posterior nucleus of the amygdala | moderate | biotinylated dextran amine (BDA) | […] the amygdalohippocampal transition area (AHi) displayed light and diffuse labeling (Fig. 3D). Within the AHi, more caudal parts contained more labeled fibers and terminals. Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88674 | Subiculum ventral part | Posterior nucleus of the amygdala | light/moderate | biotinylated dextran amine (BDA) | Collator note: terminals in the PA, and the neighboring regions. See Fig. 5E, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88734 | Subiculum ventral part | Posterior nucleus of the amygdala | light | biotinylated dextran amine (BDA) | Collator note: possibly several labeled terminals and fibers in the lateral part of the PA. See Fig. 8D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88767 | Subiculum ventral part | Posterior nucleus of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88798 | Subiculum ventral part | Posterior nucleus of the amygdala | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to COApm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88614 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part medial zone | light/moderate | biotinylated dextran amine (BDA) | Labeled axons were relatively sparsely distributed in the dorsal two-thirds of the PMCo (Fig. 3D). Collator note: PMCo is mapped here onto COApm, caudally. Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88675 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part medial zone | light/moderate | biotinylated dextran amine (BDA) | Collator note: dorsal labeling of the COAPm, layers II-III. See Fig. 5D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88733 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part medial zone | light/moderate | biotinylated dextran amine (BDA) | Collator note: COApm is labeled caudally, in layer 3. See Fig. 8D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88768 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part medial zone | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88796 | Subiculum ventral part | Cortical nucleus of the amygdala posterior part medial zone | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to BLAp
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88616 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | The medial half of the posterior basolateral nucleus (BLP) showed weak labeling (Fig. 3D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88659 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | moderate/strong | biotinylated dextran amine (BDA) | The distribution density of labeled fibers in the basolateral nuclear group was higher in case R64. Collator note: strong labeling of the BLAp, caudalmost. See Fig. 5D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88727 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | light | biotinylated dextran amine (BDA) | Collator note: few labeled terminals in this level. Fig 8C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88728 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeld of the BLAp, caudally. See Fig. 8D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88749 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | […] the BLP was weakly labeled (Fig. 10B). Collator note: Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88751 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | moderate/strong | biotinylated dextran amine (BDA) | 11B). Caudal regions of the BLP showed moderate-to-intense labeling with apparent lateral predominance (Fig. 10D). Collator note: Swanson Atlas Levels 30-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88783 | Subiculum ventral part | Basolateral nucleus of the amygdala posterior part | moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the caudal BLAp. See Fig. 12C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to CP
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88618 | Subiculum ventral part | Caudoputamen | light/moderate | biotinylated dextran amine (BDA) | Collator note: label in the ventrocaudal corner of the CP. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to PAA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88623 | Subiculum ventral part | Piriform-amygdaloid area | not present | biotinylated dextran amine (BDA) | Collator note: no label found in the cortical amygdalar nuclei. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88676 | Subiculum ventral part | Piriform-amygdaloid area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. See Fig. 5D-E, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88736 | Subiculum ventral part | Piriform-amygdaloid area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. See Fig. 8D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88765 | Subiculum ventral part | Piriform-amygdaloid area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88797 | Subiculum ventral part | Piriform-amygdaloid area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to EPv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88619 | Subiculum ventral part | Endopiriform nucleus ventral part | not present | biotinylated dextran amine (BDA) | Collator note: no labeling of the Epv. See Fig. 3C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88661 | Subiculum ventral part | Endopiriform nucleus ventral part | light | biotinylated dextran amine (BDA) | The BLV showed very light labeling (Fig. 5B,C) that did not receive efferents from the rostral Sv (Fig. 3B,C). Collator note: BLV is mapped here as Epv. See Fig. 5B-C, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88737 | Subiculum ventral part | Endopiriform nucleus ventral part | light | biotinylated dextran amine (BDA) | Collator note: Epv (BLV) has several labeled fibers and terminals. See Fig. 8B-C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88748 | Subiculum ventral part | Endopiriform nucleus ventral part | very strong | biotinylated dextran amine (BDA) | Many labeled fibers also accumulated in the medial edge of the La as well as in the dorsomedial quadrant of the BLV (Fig. 10B). Collator note: Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88784 | Subiculum ventral part | Endopiriform nucleus ventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the EPv, rostrocaudally. See Fig. 10B-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to TR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88624 | Subiculum ventral part | Postpiriform transition area | not present | biotinylated dextran amine (BDA) | Collator note: no label found in the cortical amygdalar nuclei. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88677 | Subiculum ventral part | Postpiriform transition area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. See Fig. 5D-E, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88735 | Subiculum ventral part | Postpiriform transition area | not present | biotinylated dextran amine (BDA) | Collator note: no label in TR, at least rostrally. See Fig. 8D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88799 | Subiculum ventral part | Postpiriform transition area | not present | biotinylated dextran amine (BDA) | Collator note: no label in this region. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to PIR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88622 | Subiculum ventral part | Piriform area | not present | biotinylated dextran amine (BDA) | Collator note: PIR does not include any labeled terminals at least caudally. See Fig. 3A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88679 | Subiculum ventral part | Piriform area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the PIR, at least caudally. See Fig. 5A-E, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88739 | Subiculum ventral part | Piriform area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal part of the PIR. See fig. 8 A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88772 | Subiculum ventral part | Piriform area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal part of the PIR. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88800 | Subiculum ventral part | Piriform area | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal part of the PIR. See fig. 12 A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88740 | Subiculum ventral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88775 | Subiculum ventral part | Entorhinal area, lateral part | moderate/strong | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88804 | Subiculum ventral part | Entorhinal area, lateral part | moderate | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans |
Details about the neuroanatomical projections from SUBv to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88741 | Subiculum ventral part | Perirhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88774 | Subiculum ventral part | Perirhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88803 | Subiculum ventral part | Perirhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans |
Details about the neuroanatomical projections from SUBv to AAA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88680 | Subiculum ventral part | Anterior amygdaloid area | moderate | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88743 | Subiculum ventral part | Anterior amygdaloid area | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88777 | Subiculum ventral part | Anterior amygdaloid area | moderate | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88806 | Subiculum ventral part | Anterior amygdaloid area | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88808 | Subiculum ventral part | Anterior amygdaloid area | light | biotinylated dextran amine (BDA) | Only a few BDA-labeled fibers were scattered in the anterior amygdaloid area and nucleus of the lateral olfactory tract at a rostralmost level. Collator note: projection not shown | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R64, the BDA injection site was on the lateral portion of the caudal Sv (Fig. 1C). Collator note: injection completely included in the SUBv, mid-rostrocaudal. The injection site is annotated here onto Swanson Atlas Level 39 (-6.0 mm from bregma). |
Details about the neuroanatomical projections from SUBv to BA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88625 | Subiculum ventral part | Bed nucleus of the accessory olfactory part | not present | biotinylated dextran amine (BDA) | Collator note: no label found in the cortical amygdalar nuclei. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88663 | Subiculum ventral part | Bed nucleus of the accessory olfactory part | not present | biotinylated dextran amine (BDA) | Collator note: the BA seems void of label. See Fig. 5A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88712 | Subiculum ventral part | Bed nucleus of the accessory olfactory part | not present | biotinylated dextran amine (BDA) | Collator note: no fibers in the BA. See Fig. 8A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88758 | Subiculum ventral part | Bed nucleus of the accessory olfactory part | not present | biotinylated dextran amine (BDA) | Collator note: no label in the caudal MEAav and the neighboring BA. See Fig. 10A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: Collator note: BDA injection in the rostral SUBv, more laterally placed. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm from bregma). See Fig 1A. |
Details about the neuroanatomical projections from SUBv to ECT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88742 | Subiculum ventral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in the deep layers (IV-V) of the rostral ENTl, ECT, and PERI. See Fig. 8C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88776 | Subiculum ventral part | Ectorhinal area | moderate/strong | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88805 | Subiculum ventral part | Ectorhinal area | moderate | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R50, the BDA injection was placed on the ventral portion of the Si (Fig. 1E). Collator note: injection in the caudal-ventral part of the SUBv. The injection site is completely included in the region. The injection site is annotated here onto Swans |
Details about the neuroanatomical projections from SUBv to AIp
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88773 | Subiculum ventral part | Agranular insular area posterior part | moderate/strong | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 10 A-D, Swanson Atlas Levels 26-31. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88802 | Subiculum ventral part | Agranular insular area posterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: moderate-strong labeling of the cortical regions around the rhinal fissure, rostrocaudally: caudal Aip and rostral ENTl, PERI, and ECT. Layers III-VI are labeled. See fig. 12 A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R70, BDA was injected into the mid-dorsoventral portion of the Si (Figs. 1E, 9). Collator note: injection in the caudal-intermediate part of the SUBv. The injection site is completely included in the region. The injection site is annotated here on |
Details about the neuroanatomical projections from CA1 to NLOT
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88655 | Field CA1 | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88710 | Field CA1 | Nucleus of the lateral olfactory tract | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to MEAad
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88633 | Field CA1 | Medial nucleus of the amygdala anterodorsal part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88694 | Field CA1 | Medial nucleus of the amygdala anterodorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: Fig 7A, Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to MEAav
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88634 | Field CA1 | Medial nucleus of the amygdala anteroventral part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88695 | Field CA1 | Medial nucleus of the amygdala anteroventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: Fig 7A, Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to CEAm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88641 | Field CA1 | Central nucleus of amygdala medial part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88697 | Field CA1 | Central nucleus of amygdala medial part | moderate | biotinylated dextran amine (BDA) | Collator note: Fig 7A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to CEAl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88639 | Field CA1 | Central nucleus of amygdala lateral part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88698 | Field CA1 | Central nucleus of amygdala lateral part | very light | biotinylated dextran amine (BDA) | Collator note: few fibers in the CEAl, rostrocaudally. See Fig. 7A-C, Swanson Atlas Levels 25-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to CEAc
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88640 | Field CA1 | Central nucleus of amygdala capsular part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-C, Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88682 | Field CA1 | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | At a rostral level, moderate numbers of labeled fibers were distributed in a narrow vertical area between the central nucleus and BLA (Fig. 7A). Collator note: the band is annotated here in the rostral CEAc. See Fig. 7A, Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88696 | Field CA1 | Central nucleus of amygdala capsular part | moderate | biotinylated dextran amine (BDA) | Collator note: Fig 7A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to IA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88626 | Field CA1 | Intercalated nuclei of the amygdala | strong | biotinylated dextran amine (BDA) | Characteristically, CA1 fibers labeled with BDA accumulated densely in the intercalated nucleus (Fig. 4A–C). Collator note: dense labeling of the IA, especially caudally. Swanson Atlas Levels 26-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88683 | Field CA1 | Intercalated nuclei of the amygdala | moderate/strong | biotinylated dextran amine (BDA) | The intercalated nucleus displayed moderate-tointense labeling especially at rostral levels (Fig. 7A). Collator note: Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to BMAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88648 | Field CA1 | Basomedial nucleus of the amygdala anterior part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88686 | Field CA1 | Basomedial nucleus of the amygdala anterior part | moderate | biotinylated dextran amine (BDA) | Collator note: BMAa is at least moderately labeled rostrocaudally. See fig. 7A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to EPd
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88643 | Field CA1 | Endopiriform nucleus dorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the caudalmost part of the Epd. See Fig. 4D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88704 | Field CA1 | Endopiriform nucleus dorsal part | light | biotinylated dextran amine (BDA) | Collator note: few fibers and terminals in the Epd, caudally. See Fig. 7A-D, Swanson Atlas Levels 25-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to MEApd
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88632 | Field CA1 | Medial nucleus of the amygdala posterodorsal part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4B-C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88702 | Field CA1 | Medial nucleus of the amygdala posterodorsal part | light/moderate | biotinylated dextran amine (BDA) | Collator note: uniform terminal field in the MEAp, especially in mode rostral part. See Fig. 7B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to COAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88649 | Field CA1 | Cortical nucleus of the amygdala anterior part | not present | biotinylated dextran amine (BDA) | Collator note: basically no labeled fibers in the COAa. See Fig. 4A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88700 | Field CA1 | Cortical nucleus of the amygdala anterior part | light/moderate | biotinylated dextran amine (BDA) | Collator note: label of layer II. See Fig. 7A-B, Swanson Atlas Levels 25-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to COApl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88635 | Field CA1 | Cortical nucleus of the amygdala posterior part lateral zone | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88688 | Field CA1 | Cortical nucleus of the amygdala posterior part lateral zone | moderate/strong | biotinylated dextran amine (BDA) | At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to MEApv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88631 | Field CA1 | Medial nucleus of the amygdala posteroventral part | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4B-C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88701 | Field CA1 | Medial nucleus of the amygdala posteroventral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: uniform terminal field in the MEAp, especially in mode rostral part. See Fig. 7B, Swanson Atlas Levels 27-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to BMAp
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88629 | Field CA1 | Basomedial nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | Relatively small numbers of labeled fibers were seen in the BMP (Fig. 4C,D). Collator note: Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88687 | Field CA1 | Basomedial nucleus of the amygdala posterior part | strong | biotinylated dextran amine (BDA) | Collator note: strong labeling of the BMAp, rostrocaudally. See Fig. 7C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to BLAa
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88627 | Field CA1 | Basolateral nucleus of the amygdala anterior part | moderate/strong | biotinylated dextran amine (BDA) | The BLA displayed moderate labeling with caudal predominance (Fig. 4B,C). Collator note: increase of labeling of the BLAa from almost no label (Fig. 4A, Swanson Atlas Levels 26-27) to weak-moderate (Fig. 4B, Swanson Atlas Level 28), to quite strong (Fig. 4C, Swanson Atlas Level 29). | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88684 | Field CA1 | Basolateral nucleus of the amygdala anterior part | moderate/strong | biotinylated dextran amine (BDA) | Within the BLA and BLP, the distribution area of labeled fibers extended more laterally in case R65 (Fig. 7C,D) than did that in case R64 (Fig. 5C,D). Collator note: Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to LA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88638 | Field CA1 | Lateral nucleus of the amygdala | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the caudoventral part of the LA. See Fig. 4D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88693 | Field CA1 | Lateral nucleus of the amygdala | moderate | biotinylated dextran amine (BDA) | Collator note: fibers and terminals in the caudal LA, tending to group ventrally. See Fig. 7C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to PA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88646 | Field CA1 | Posterior nucleus of the amygdala | very light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88692 | Field CA1 | Posterior nucleus of the amygdala | light/moderate | biotinylated dextran amine (BDA) | Collator note: clear label in PA. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to COApm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88630 | Field CA1 | Cortical nucleus of the amygdala posterior part medial zone | strong | biotinylated dextran amine (BDA) | There was an accumulation of labeled fibers in a narrow area between the Ahi and PLCo and an adjacent portion of the PLCo. Collator note: region mapped here onto layer 3 of caudal COApm. See Fig. 4D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88636 | Field CA1 | Cortical nucleus of the amygdala posterior part medial zone | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88689 | Field CA1 | Cortical nucleus of the amygdala posterior part medial zone | moderate/strong | biotinylated dextran amine (BDA) | At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to BLAp
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88628 | Field CA1 | Basolateral nucleus of the amygdala posterior part | light/moderate | biotinylated dextran amine (BDA) | The BLA displayed moderate labeling with caudal predominance (Fig. 4B,C). Collator note: Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88685 | Field CA1 | Basolateral nucleus of the amygdala posterior part | strong | biotinylated dextran amine (BDA) | Within the BLA and BLP, the distribution area of labeled fibers extended more laterally in case R65 (Fig. 7C,D) than did that in case R64 (Fig. 5C,D). Collator note: Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to CP
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88647 | Field CA1 | Caudoputamen | moderate | biotinylated dextran amine (BDA) | Collator note: label in the ventrocaudal corner of the CP. See Fig. 4C, Swanson Atlas Levels 28-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88705 | Field CA1 | Caudoputamen | light/moderate | biotinylated dextran amine (BDA) | Collator note: label in the ventral corner of the caudal CP. See Fig 7C, Swanson Atlas Level 29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to PAA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88637 | Field CA1 | Piriform-amygdaloid area | light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Fig 4A-D, Swanson Atlas Levels 26-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88690 | Field CA1 | Piriform-amygdaloid area | light/moderate | biotinylated dextran amine (BDA) | At caudalmost levels, CA1 fibers labeled with BDA relatively densely terminated in the dorsomedial portion of the PLCo and in the amygdalopiriform transition area (APir). Collator note: unclear whether this terminal field is only in COApl, or it extends into COApm. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to EPv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88644 | Field CA1 | Endopiriform nucleus ventral part | light | biotinylated dextran amine (BDA) | Collator note: labeling of the EPv, mainly dorsally. See Fig. 4B-D, Swanson Atlas Levels 26-32 | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88703 | Field CA1 | Endopiriform nucleus ventral part | light | biotinylated dextran amine (BDA) | Collator note: few fibers and terminals in the EPv (BLV of authors), rostrocaudally. See Fig. 7B-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to TR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88645 | Field CA1 | Postpiriform transition area | very light | biotinylated dextran amine (BDA) | Many of other amygdaloid nuclei showed extremely light labeling (Fig. 4A–D). Collator note: Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88691 | Field CA1 | Postpiriform transition area | light | biotinylated dextran amine (BDA) | Collator note: at least several labeled terminals in the rostralmost TR. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to PIR
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88650 | Field CA1 | Piriform area | moderate | biotinylated dextran amine (BDA) | Collator note: increase of the labeling of the PIR, caudally. The highest labeling in shown in Fig 4D, Swanson Atlas Levels 31-32, layer II. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88706 | Field CA1 | Piriform area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the caudalmost part of the PIR, layer II. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to ENTl
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88651 | Field CA1 | Entorhinal area, lateral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the deep layers III-VI of the rostral ENTl and of the PERI. See Fig. 4C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88707 | Field CA1 | Entorhinal area, lateral part | light/moderate | biotinylated dextran amine (BDA) | Collator note: label of the rostral levels of the ENTl and PERI, layers III-VI. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to PERI
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88652 | Field CA1 | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: labeling of the deep layers III-VI of the rostral ENTl and of the PERI. See Fig. 4C-D, Swanson Atlas Levels 29-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88708 | Field CA1 | Perirhinal area | light/moderate | biotinylated dextran amine (BDA) | Collator note: label of the rostral levels of the ENTl and PERI, layers III-VI. See Fig. 7D, Swanson Atlas Levels 31-32. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to CLA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88653 | Field CA1 | Claustrum | light/moderate | biotinylated dextran amine (BDA) | Collator note: group of terminals in the caudal part of the CLA, just above the Epd. See Fig 4A-B, Swanson Atlas Levels 26-28. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to AAA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88654 | Field CA1 | Anterior amygdaloid area | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88709 | Field CA1 | Anterior amygdaloid area | light | biotinylated dextran amine (BDA) | Collator note: data shown in Table 1, page 365. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Details about the neuroanatomical projections from CA1 to BA
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 88642 | Field CA1 | Bed nucleus of the accessory olfactory part | not present | biotinylated dextran amine (BDA) | Collator note: no labeling in BA, at least caudally. See Fig. 4A, Swanson Atlas Levels 26-27. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 | |
| 88699 | Field CA1 | Bed nucleus of the accessory olfactory part | very light | biotinylated dextran amine (BDA) | Collator note: 1-2 labeled fibers in the BA. See Fig.7A, Swanson Atlas Levels 25-26. | Kishi T., Tsumori T., Yokota S. & Yasui Y. , 2006 |
| General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
